Modeus partners with WellSky

WellSky logo

Modeus and WellSky partner to deliver electronic controlled drug management to global markets

Australian healthcare software company Modeus is thrilled to announce a partnership with WellSky International Ltd, providers of the UK’s leading digital medicines management platform (Pharmacy, EPMA and Chemotherapy).

Under the agreement, WellSky will sell a branded version of HS8 called “WellSky CD Manager” to its customers in Ireland and the UK, with plans to extend to the Netherlands, Belgium, Norway, Sweden and South Africa in the future.

The solution eliminates the need for controlled drug paper records, which have been identified as a potential source of infection in recent reviews covering hospital hygiene and safety during the
pandemic. It is integrated with WellSky systems to deliver seamless controlled drug management while helping to improve governance and compliance.

Rob Tysall-Blay, CEO of Wellsky International, commented; “WellSky is delighted to partner with Modeus on this journey. CD Manager is an important new addition to the WellSky Medicines Management Platform and provides hospitals with a paperless solution for their controlled drug processes. We anticipate a great deal of interest in this latest expansion to the WellSky suite.

Carl Zufi, CEO of Modeus commented; We are very excited to be partnering with WellSky International to deliver our innovative controlled drug management platform to global markets.

WellSky International has a comprehensive medication management platform and WellSky CD Manager extends and compliments this to provide a fully integrated solution unmatched anywhere else. As the use of controlled drugs in hospitals continues to grow at a rapid rate, the need to move away from inefficient manual paper based systems is critical. WellSky CD Manager has been specifically designed to address this challenge.

About WellSky International

WellSky International Ltd is a wholly owned subsidiary of WellSky Inc which serves more than 14,000 client sites around the world — including hospital systems, blood banks, home health and hospice franchises, government agencies, and human services organisations. For more information on WellSky International Ltd visit www.wellsky.org

HS8 goes live at Peter Mac wards

HS8 in use at Peter MacCallum Cancer Centre

Modeus are excited to announce that HS8, our hospital electronic controlled drug register platform, is now live at Peter MacCallum Cancer Centre wards.

HS8 will allow nurses to electronically record controlled drug usage and sign off with their existing Imprivata tap cards, saving time while improving governance. In the absence of face-to-face training due to the pandemic, our online training platform has been crucial for onboarding new users and we expect it to play a big role in future implementations.

Modeus would like to give special thanks to the Pharmacy, IT and Nursing teams at Peter Mac for their collaboration during the rollout of the software-lead controlled drug management solution.

Modeus at eMedication Management Conference 2020

Modeus presented HS8 as a hospital-wide medication management solution alongside our partners, Debetrek & Humanscale. The exhibit was also supported with a presentation by Peter Blewitt (Peninsula Health) and a fireside chat with leaders from each company discussing innovations in medication from pharmacy to the bedside.

For sales enquiries call us on (03) 9867 2785